Reverse control of irreversible biological phenomena
|Kwang-Hyun Cho is a Professor in the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIST) and a director of the Laboratory for Systems Biology and Bio-inspired Engineering (http://sbie.kaist.ac.kr). He started systems biology by his own idea of combining control engineering and biology from 1999 and has published over 210 papers in high-profile international journals. He has been developing new therapeutic principles for reverting cancer and aging through systems biological approach. He is the Editor-in-Chief of IET Systems Biology (IET & Wiley, London) and Encyclopedia of Systems Biology (Springer, New York).
Why Networks Matter: Embracing Biological Complexity
|John Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor in the Channing Division of Network Medicine at Brigham and Women’s Hospital and in the Department of Data Science at the Dana-Farber Cancer Institute. John’s PhD was in Theoretical Physics, but in 1992 he received a fellowship to work on the Human Genome Project. This led him through the Salk Institute, Stanford University, and The Institute for Genomic Research (TIGR), before moving to Harvard in 2005. John’s research uses massive data to probe how many small effects combine to influence our health and risk of disease. He has published more than 320 scientific papers that have collectively been cited over 85,000 times and among his honors is recognition in 2013 as a White House Open Science Champion of Change. In 2012, he founded Genospace, a precision medicine software company providing data platforms to hospitals, diagnostic testing labs, and other groups. In 2017, Genospace was purchased by the Hospital Corporation of America. He serves on numerous advisory boards, including those of Merck KGaA, Caris Life Sciences, and RenalytixAI.